The FDA just approved a new antidepressant, the first of its kind. Unlike other antidepressants, this one is a nasal spray. Esketamine, under the brand name Spravato, is developed by Johnson & Johnson and has been in testing for the past 2 years. The drug has seen remarkable success. This success is interesting because the drug is closely tied to the club drug “Special K.” Related to MDMA, Special K is known as Ecstasy. This marks the first major breakthrough in the treatment of depression since the 1980s.
Dane Larsen | @_danebailey
Decriminalization of historically denounced psychedelic drugs, which alter the state of consciousness, is more prevalent than the public often sees. This ties back to religious and transcendental experiences that played a role in human evolution. The scope goes as far back as 7,000 years ago to the first ideas of “Big Gods” and anything of that nature, as Ishmael Apud, Professor at Universidad de la República de Uruguay, analyzes. It occurs in primary documents of the ancient civilizations and modern scientific studies alike.
From the research, it is clear that psychedelics have had a prominent place in society for thousands of years. In fact, only the arbitrary regulations of governments of the Church have barred the use of such drugs. Governments have taken this position to save citizens from themselves. However, the history of psychedelics presents evidence of beneficial effects on the body, individual, and society. Continue reading “Psychedelics: A Historical Account of Use and Rejection”